Based on surveillance inputs and its internal alert system, Sebi initiated examination of suspected front running by persons associated with certain market experts appearing on a business news channel. The modus-operandi of these entities was that they took positions in stocks just before recommendations were made by their associated market experts on the channel.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.